Measurement of a novel serological marker for pancreatic cancer in esophageal, gastric, hepatic, bile duct and colorectal cancers

ABSTRACT: Primary outcome(s): Comparison of the IGFP levels between patients of Esohageal, gastric, hapatic, bile duct, colorectal cancers and control individuals

DISEASE(S): Esohageal Cancer, Gastric Cancer, Hapatic Cancer, Bile Duct Cancer, Colorectal Cancer

PROVIDER: 2643115 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR